Fully covered metal stents
DeviceFully covered metal stents were inserted by ERCP
Other names: BONASTENT, Standard Sci Tech, Seoul, Korea
NCT Number: NCT01789502
This study is a prospective, randomized study to compare of outcome of fully covered metal stents with that of plastic stents for preoperative biliary drainage in distal common bile duct cancer, pancreas head cancer or ampullary cancer with respect to the incidence of stent-related adverse events, the re-intervention rate, the effectiveness of biliary drainage, surgical outcomes and hospital stays.
Looking for future studies?
Notify Me20 year and older
All sexes
Interventional
Not applicable
Daejun Eulji University Hospital, Daejun, South Korea
Pancreaticoduodenectomy is curative option in periampullary tumor. Preoperative endoscopic retrograde cholangiopancreatog-raphy (ERCP) is usually undertaken in patients with resectable disease to relieve biliary obstruction, which is thought to impair immune response, clotting, and other functions that impact intraoperative and postoperative outcomes. Despite conflicting data pertaining to preoperative biliary drainage, ERCP with biliary stenting has become standard practice in patients with periampullary malignancies. In a recent multicenter randomized trial, patients who underwent preoperative biliary drainage had a 74% rate of complications compared with 39% for those who directly underwent surgery without preoperative biliary drainage. In this trial, however, all patients underwent placement of plastic stents. In ERCP, self-expandable metal stent are being increasingly placed for palliation of malignant biliary obstruction. Compared with plastic stents, self-expandable metal stents have large caliber and have demonstrated longer patency duration. Even in patients with resectable malignant disease, self-expandable metal stents which are placed below the level of transection may not impair technical outcomes at surgery and can be safely removed along with the surgical specimen.
This prospective study is designed to compare the incidence of stent-related adverse events, the re-intervention rate, the effectiveness of biliary drainage, surgical outcomes and hospital stays in patients with periamupllary tumors who are undergone with self-expandable metal stents or plastic stents placement for preoperative biliary drainage
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Fully covered metal stents were inserted by ERCP
Other names: BONASTENT, Standard Sci Tech, Seoul, Korea
Plastic stents were inserted by ERCP
Other names: Biliary stents, Cook Endoscopy, Winston-Salem, NC
Time frame: up to 4weeks
Primary outcome parameter is adverse events related to the stent insertion includes post-ERCP pancreatitis, cholecystitis, cholangitis, bowel perforation or hemorrhage.
Time frame: up to 4weeks
Re-intervention is defined as endoscopic retrograde cholangiopancreatography or percutaneous transhepatic biliary drainage procedures which are required to achieve adequate preoperative biliary drainage after stent insertion.
Time frame: up to 1months
Hospital stay is defined as the period between the date of stent insertion and that of discharge.
Time frame: up to 1months
Surgical outcomes include the complete resection rate, complication rates related to surgery or the amount of transfusion during surgery.
Inje University
Other
Are Fully Covered Metal Stents Superior to Plastic Stents for Preoperative Biliary Decompression in Malignant Distal Bile Duct Obstruction?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03724994
Digestive System Diseases, Digestive System Neoplasms
Malmö, Skåne County, Sweden
View Trial DetailsNCT04985071
Bleeding, Digestive System Diseases
Ho Chi Minh City, Vietnam
View Trial DetailsNCT03870698
Functional Recovery, Laparoscopy
Seoul, South Korea
View Trial DetailsNCT04401722
Altitude Sickness, Periampullary Cancer
Al Mansurah, Egypt
View Trial Details